Litigation Details for Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd. (D. Del. 2021)
Docket | ⤷ Subscribe | Date Filed | 2021-07-30 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Parties | DANA-FARBER CANCER INSTITUTE, INC. | ||
Patents | 7,973,031; 8,222,244; 8,575,146 | ||
Attorneys | Steven H. Sklar | ||
Firms | Shaw Keller LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd.
Details for Novartis Pharmaceuticals Corporation v. Lotus Pharmaceutical Co., Ltd. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-07-30 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,973,031 ;8,222,244 ;8,575,146… 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-04-06 | 45 | Stipulation of Dismissal | Claims Against Defendant Lotus Regarding U.S. Patent No. 8,222,244 Pursuant to Rule 41(a)(1)(A)(iii) Without… 30 July 2021 1:21-cv-01107 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |